Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 2/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | ACLY | P53396 | 2/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.42 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CTRC | Q99895 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30902582 | 1.00 | APP (0.51) | APPEGFRACLYHSD17B1HSD17B2 | |
| SCHEMBL21476277 | 0.91 | APP (0.57) | APPACLYHSD17B1HSD17B2CA1 | |
| SCHEMBL21476765 | 0.91 | APP (0.56) | APPHSD17B1HSD17B2CA1CA2 | |
| SCHEMBL21476444 | 0.89 | APP (0.49) | APPACLYHSD17B1HSD17B2CA1 | |
| SCHEMBL31008503 | 0.89 | APP (0.49) | APPACLYHSD17B1HSD17B2CA1 | |
| SCHEMBL31008496 | 0.88 | APP (0.49) | APPACLYHSD17B1HSD17B2CA1 | |
| SCHEMBL21476442 | 0.88 | APP (0.49) | APPACLYHSD17B1HSD17B2CA1 | |
| SCHEMBL21557143 | 0.86 | APP (0.56) | APPHSD17B1HSD17B2CA1CA2 | |
| SCHEMBL21476763 | 0.85 | APP (0.69) | APPACLYHSD17B1HSD17B2CA1 | |
| SCHEMBL26644197 | 0.85 | APP (0.51) | APPHSD17B1HSD17B2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3667753-B1 | ORGANIC LIGHT EMITTING DEVICE AND A COMPOUND FOR USE THEREIN | NOVALED GMBH (DE) | 2025-04-23 | — | — | EP | disclosed |
| CN-112135822-B | N-heteroarylene compounds with low LUMO energy | 诺瓦尔德股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-3790875-B1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2024-07-03 | — | — | EP | disclosed |
| EP-3790875-B1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2024-07-03 | — | — | EP | disclosed |
| EP-3567039-B1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2024-05-08 | — | — | EP | disclosed |
| EP-3895226-B1 | ORGANIC LIGHT EMITTING DEVICE AND A COMPOUND FOR USE THEREIN | NOVALED GMBH (DE) | 2023-10-25 | — | — | EP | disclosed |
| US-20220029103-A1 | Organic Light Emitting Device and a Compound for Use Therein | NOVALED GMBH (DE) | 2022-01-27 | — | — | US | disclosed |
| US-20220029103-A1 | Organic Light Emitting Device and a Compound for Use Therein | NOVALED GMBH (DE) | 2022-01-27 | — | — | US | disclosed |
| CN-113228326-A | Organic light emitting device and compound used therein | 诺瓦尔德股份有限公司 | 2021-08-06 | — | — | CN | disclosed |
| EP-3790875-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | Novaled GmbH (DE) | 2021-03-17 | — | — | EP | disclosed |
| EP-3667753-A2 | ORGANIC LIGHT EMITTING DEVICE AND A COMPOUND FOR USE THEREIN | Novaled GmbH (DE) | 2020-06-17 | — | — | EP | disclosed |
| WO-2019215179-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2019-11-14 | — | — | WO | disclosed |
| WO-2019215179-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2019-11-14 | — | — | WO | disclosed |
| EP-3567039-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | Novaled GmbH (DE) | 2019-11-13 | — | — | EP | disclosed |
| EP-3567039-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | Novaled GmbH (DE) | 2019-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220029103-A1 | Organic Light Emitting Device and a Compound for Use Therein | CYBA, CYP1A2, AOX1 | APP 1742/4885EGFR 3721/4885ACLY 1532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.